Specialty Pharma ApS: Financial statements 2018
CVR: 38476599
Source: annual report 2018, Danish Business Authority
01/01/2018 – 31/12/2018
Specialty Pharma ApS (CVR 38476599) has filed annual accounts for 2018. In 2018, the company reported a gross profit of DKK 109,840 and a net result of DKK -1,875. Equity in the 2018 report amounted to DKK 70,656. The solvency ratio was 51.5%. The company had 1 employee in the financial year.
- Gross Profit
- DKK 109,840
- Profit/Loss
- DKK -1,875
- Equity
- DKK 70,656
- Total Assets
- DKK 137,318
- Employees
- 1
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2018
Specialty Pharma ApS has published its interim report for the period March 15, 2017 – December 31, 2017.
About Specialty Pharma ApS
Specialty Pharma ApS is a Danish company of the type Anpartsselskab based in Holte, founded in 2017. The company is registered under the industry Virksomhedsrådgivning og anden ledelsesrådgivning. The management consists of Ulla Haaning Singapuri. The company is owned by Ulla Haaning Singapuri. The company has 1 employee (2018). In 2025, the company reported a gross profit of DKK 216,735 and a net result of DKK -58,566 compared with DKK -53,758 the year before. Equity in the 2025 report amounted to DKK -17,816.